Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MGA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | FNDC3A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RALGPS2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | EFCAB5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NPAS2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | HMGCLL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PCDHA5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | WFIKKN2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | KIF26A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | C3orf58 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |